Document is current
Any future updates will be listed below
-
Authors
Henderson, Neil C. https://orcid.org/0000-0002-2273-4094
Rieder, Florian
Wynn, Thomas A. https://orcid.org/0000-0002-7244-8731
- License Information
-
More Information
Article History
Received: 4 May 2020
Accepted: 14 September 2020
First Online: 25 November 2020
Competing interests
: N.C.H. has received research funding from AbbVie, Pfizer, Gilead and Galecto, and is an advisor or consultant for Galecto, Indalo Therapeutics, Pliant Therapeutics, GSK and Boehringer-Ingelheim. F.R. is an advisor or consultant for AbbVie, Allergan, BMS, Boehringer-Ingelheim, Celgene, Falk Pharma, Gilead, Genentech, Gossamer, GSK, Receptos, Thetis, UCB, Samsung, Koutif, Pliant Therapeutics, Metacrine, Takeda, Theravance, Pfizer, Agomab, Helmsley, RedX and Roche. T.A.W. is employed by Pfizer.
